Skip to main content

2022

Journal Paper with direct contribution

  1. Adriana M. Saur, Jorge Sinval, Cristina M. Del-Ben, Rosângela F. L. Batista8, Antônio A. M. Da Silva, Marco A. Barbieri1, Heloisa Bettiol1 The Postpartum Bonding Questionnaire: validity evidence from the Brazilian version; Journal of Child and Family Studies (https://doi.org/10.1007/s10826-022-02406-x)
  2. João A.Marques da SilvaaMiguelVieira de CarvalhoabRui P.Cardoso CoelhoabIgor A.Rodrigues LopesabFrancisco M.Andrade Piresab On the representativeness of polycrystalline models with transformation induced plasticity; Finite Elements in Analysis and Design (https://doi.org/10.1016/j.finel.2022.103875)
  3. Aggregation of a Parkinson’s Disease-Related Peptide: When Does Urea Weaken Hydrophobic Interactions? N. Galamba* Cite this: ACS Chem. Neurosci. 2022, 13, 12, 1769–1781 Publication Date:May 26, 2022 (https://doi.org/10.1021/acschemneuro.2c00169)
  4. Gadelho, J., Guedes Soares, C., Barajas, G., & Lara, J. L. (2022). CFD analysis of the PTO damping on the performance of an onshore dual chamber OWC. In C. Guedes Soares & T. A. Santos, Trends in Maritime Technology and Engineering Volume 2 (1st ed., pp. 381–389). CRC Press. https://doi.org/10.1201/9781003320289-40
  5. Gadelho, J., & Guedes Soares, C., (2022). Pneumatic performance improvement of an onshore dual chamber OWC using a CFD model. In Trends in Renewable Energies Offshore (Guedes Soares C., (Ed.)). https://doi.org/10.1201/9781003360773-36

Patents

  1. EP21306547 / BNT231376EP00 - Vincent Parissi, Sérgio F. Sousa, D. Lapaillere, O. Delelis, L. Meertens, S. Gallois-Montbrun, S. Routier - Pharmaceutical composition, its use as a drug and new compounds, especially for treating SARS-CoV-2 infection (Indole derivaties) 04 November 2021

  2. EP21306521 / BNT231394EP00 - Vincent Parissi, Sérgio F. Sousa, D. Lapaillere, O. Delelis, L. Meertens, S. Gallois-Montbrun, M. Teulade-Fichou, R. Lartia, G. Bordeau - Pharmaceutical composition, its use as a drug and new compounds, especially for treating SARS-CoV-2 infection (triphenylamine derivatives) 29 October 2021

Back to top